
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you open and fund a new account within 30 days
- Access to a financial planner
Danaher Corporation is a diagnostics & research business based in the US. Danaher Corporation shares (DHR) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $197.40 – a decrease of 0.77% over the previous week. Danaher Corporation employs 61,000 staff and has a trailing 12-month revenue of around $23.8 billion.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Latest market close | $197.40 |
---|---|
52-week range | $171.00 - $280.67 |
50-day moving average | $201.35 |
200-day moving average | $237.53 |
Wall St. target price | $247.17 |
PE ratio | 38.5756 |
Dividend yield | $1.13 (0.64%) |
Earnings per share (TTM) | $5.16 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $199.05 from 2025-05-02
1 week (2025-04-29) | 0.06% |
---|---|
1 month (2025-04-07) | 10.20% |
3 months (2025-02-07) | -3.73% |
6 months (2024-11-07) | -19.12% |
1 year (2024-05-07) | -19.98% |
---|---|
2 years (2023-05-05) | -6.53% |
3 years (2022-05-06) | 218.0473 |
5 years (2020-05-06) | 39.69% |
Valuing Danaher Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Danaher Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Danaher Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 39x. In other words, Danaher Corporation shares trade at around 39x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Danaher Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.9572. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Danaher Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Danaher Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $7.5 billion.
The EBITDA is a measure of a Danaher Corporation's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | $23.8 billion |
---|---|
Operating margin TTM | 22.49% |
Gross profit TTM | $14.2 billion |
Return on assets TTM | 3.93% |
Return on equity TTM | 7.22% |
Profit margin | 15.81% |
Book value | $71.06 |
Market Capitalization | $142.5 billion |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Danaher Corporation.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 32.72
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Danaher Corporation's overall score of 32.72 (as at 12/31/2018) is pretty weak – landing it in it in the 66th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Danaher Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 4.13/100
Danaher Corporation's environmental score of 4.13 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Danaher Corporation is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 17.73/100
Danaher Corporation's social score of 17.73 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Danaher Corporation is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 7.86/100
Danaher Corporation's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Danaher Corporation is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Danaher Corporation scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Danaher Corporation has, for the most part, managed to keep its nose clean.
Danaher Corporation was last rated for ESG on: 2019-01-01.
Total ESG score | 32.72 |
---|---|
Total ESG percentile | 65.84 |
Environmental score | 4.13 |
Environmental score percentile | 1 |
Social score | 17.73 |
Social score percentile | 1 |
Governance score | 7.86 |
Governance score percentile | 1 |
Level of controversy | 2 |
Dividend payout ratio: 15.17% of net profits
Recently Danaher Corporation has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Danaher Corporation shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Danaher Corporation's case, that would currently equate to about $1.13 per share.
While Danaher Corporation's payout ratio might seem low, this can signify that Danaher Corporation is investing more in its future growth.
Danaher Corporation's most recent dividend payout was on 24 April 2025. The latest dividend was paid out to all shareholders who bought their shares by 27 March 2025 (the "ex-dividend date").
Danaher Corporation's shares were split on a 1128:1000 basis on 1 October 2023 . So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1128 shares. This wouldn't directly have changed the overall worth of your Danaher Corporation shares – just the quantity. However, indirectly, the new 11.3% lower share price could have impacted the market appetite for Danaher Corporation shares which in turn could have impacted Danaher Corporation's share price.
Over the last 12 months, Danaher Corporation's shares have ranged in value from as little as $171 up to $280.6687. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Danaher Corporation's is 0.895. This would suggest that Danaher Corporation's shares are less volatile than average (for this exchange).
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. Its Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services in the areas of clinical chemistry, immunoassay, hematology, and microbiology for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984.
Track the progress of the S&P 500 stocks to make more informed investment decisions.
See our picks for the best brokers for trading S&P 500 stocks, ETFs, options and futures.
These are the stocks to buy when you don’t have much to spend.
Explore the best bonuses for opening a new brokerage account.
Compare pros, cons, research tools and reviews for these two trading platforms.
Some of the best trading apps like Robinhood are SoFi, Tastytrade, Public, eToro, Acorns, Interactive Brokers, E*TRADE and more.
Compare pros, cons, research tools and reviews for these two trading platforms.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
SoFi Invest is a no-fee commissions platform with both active and automated investment accounts.
Webull is a broker with zero-commission trading and a suite of tools to help you invest.